EUVIMEDEUVIMED entdecken
Crossref

Long-term efficacy and safety of PEGylated recombinant human growth hormone in treating Chinese children with growth hormone deficiency: a 5-year retrospective study

Lele Hou iD, Shaofen Lin, Zulin Liu, Lina Zhang, Hui Ou, Siqi Huang, Huilian Dai, Zhe Meng, Liyang Liang

Journal of Pediatric Endocrinology and Metabolism · 2024

DOI: 10.1515/jpem-2024-0189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Endocrinology and Metabolism, 2024. Verfasst von Lele Hou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Children's Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, P.R. China. Hauptthemen laut MEDLINE: Human Growth Hormone, Recombinant Proteins, Polyethylene Glycols. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The study endeavored to evaluate the prolonged efficacy and safety of PEGylated rhGH (PEG-rhGH) administration in Chinese children diagnosed with growth hormone deficiency (GHD) over a 5-year period.

Methods

A retrospective analysis was conducted on children with GHD, who received a 0.2 mg/kg/week dose of PEG-rhGH between 2016 and 2023 in our department.

Results

The height standard deviation score (Ht SDS) exhibited a marked elevation post-PEG-rhGH administration (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Human Growth HormoneRecombinant ProteinsPolyethylene GlycolsHumansRetrospective StudiesMaleFemaleChildFollow-Up StudiesChild, PreschoolBody HeightGrowth DisordersChinaAdolescentDwarfism, PituitaryTreatment OutcomePrognosisInsulin-Like Growth Factor IEast Asian People

Stichwörter der Autor:innen

PEGylated recombinant human growth hormonechildrenefficacygrowth hormone deficiencysafety

Substanzen

Human Growth HormoneRecombinant ProteinsPolyethylene GlycolsInsulin-Like Growth Factor I

Autor:innen und Institutionen

  • Children's Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, P.R. China.

ORCID-Profile: Lele Hou

Zitieren

APA

Hou, L., Lin, S., Liu, Z., Zhang, L., Ou, H., Huang, S., Dai, H., Meng, Z., & Liang, L. (2024). Long-term efficacy and safety of PEGylated recombinant human growth hormone in treating Chinese children with growth hormone deficiency: a 5-year retrospective study. Journal of Pediatric Endocrinology and Metabolism. https://doi.org/10.1515/jpem-2024-0189

Vancouver

Hou L, Lin S, Liu Z, Zhang L, Ou H, Huang S, et al. Long-term efficacy and safety of PEGylated recombinant human growth hormone in treating Chinese children with growth hormone deficiency: a 5-year retrospective study. Journal of Pediatric Endocrinology and Metabolism. 2024. doi:10.1515/jpem-2024-0189

BibTeX
@article{Hou2024,
  author = {Hou, Lele and Lin, Shaofen and Liu, Zulin and Zhang, Lina and Ou, Hui and Huang, Siqi and Dai, Huilian and Meng, Zhe and Liang, Liyang},
  title = {Long-term efficacy and safety of PEGylated recombinant human growth hormone in treating Chinese children with growth hormone deficiency: a 5-year retrospective study},
  journal = {Journal of Pediatric Endocrinology and Metabolism},
  year = {2024},
  doi = {10.1515/jpem-2024-0189}
}
Kostenlos starten →